CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Good start, page-46

  1. 60 Posts.
    lightbulb Created with Sketch. 7
    Thanks my friend. You are doing a great job here
    It is important to know, if cannpal can generate some cash flow near term.
    I doubt there is enough money left to finish the trials and all approvals for CPAT1.
    A little bit of cash can avoid a dilution.
    And this will be great for all shareholders.
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.